๐
Grasustek
pegfilgrastim
โ
Authorised
Biosimilar
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/grasustek